Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Explore which cards offer the highest cash back without fees, ensuring you get the most out of your spending.
27,400 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
New documents reveal Epstein used elite ties to influence major philanthropy groups, raising questions about governan...
Rising mortgage costs and tight supply keep housing affordability in the spotlight. This report examines what will ac...
Alphabet is tightening the gap with Nvidia as AI wins bolster its diversified business empire. Investors weigh the im...
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
California aims to curb the so-called buy, borrow, die strategy used by ultra-wealthy as part of a broader billionair...
Capital moves matter. Capricorn Investment Group reduced its Navitas Semiconductor stake by about 1.19 million shares...
A rising iPhone upgrade cycle is quietly lifting a little-known stock. This article breaks down why the move makes it...
A $1,000 investment in QUALCOMM in 2011 could have grown significantly by 2026, driven by a pivot from smartphones to...
Tesla reports a Q2 delivery surge to 480,126 vehicles, topping forecasts and signaling durable demand despite ongoing...
February delivered the first drop in health care payrolls in more than four years, signaling a shift in a market that...
Palantir just posted its first $1B-plus quarter, pushing it into the world’s top-25 by market value and redefining th...